UNRESECTABLE DIGESTIVE SYSTEM NEUROENDOCRINE TUMOR G2
Clinical trials for UNRESECTABLE DIGESTIVE SYSTEM NEUROENDOCRINE TUMOR G2 explained in plain language.
Never miss a new study
Get alerted when new UNRESECTABLE DIGESTIVE SYSTEM NEUROENDOCRINE TUMOR G2 trials appear
Sign up with your email to follow new studies for UNRESECTABLE DIGESTIVE SYSTEM NEUROENDOCRINE TUMOR G2, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New Two-Pronged attack on Tough-to-Treat gut tumors
Disease control Recruiting nowThis early-stage study is testing whether combining two radiation-based treatments is safe and more effective for controlling large, inoperable neuroendocrine tumors in the digestive system. Participants first receive a highly focused, external radiation treatment, followed by a …
Matched conditions: UNRESECTABLE DIGESTIVE SYSTEM NEUROENDOCRINE TUMOR G2
Phase: PHASE1 • Sponsor: Emory University • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC
-
Second shot at radiation therapy tested for returning gut tumors
Disease control Recruiting nowThis study is for adults with advanced neuroendocrine tumors in the digestive system that have spread and cannot be removed by surgery, and which have started growing again after a previous successful round of a targeted radiation therapy. It aims to see if giving a second round …
Matched conditions: UNRESECTABLE DIGESTIVE SYSTEM NEUROENDOCRINE TUMOR G2
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 30, 2026 14:31 UTC